Skip to main content
Premium Trial:

Request an Annual Quote

GeneProt, Zymark Pen Automation Partnership

NEW YORK, March 4 - GeneProt has agreed to purchase four Zymark proteomics systems in an exclusive automation technology deal, the two companies said on Monday.

 

Under the terms of the arrangement, GeneProt will install two of Zymark's Staccato proteomics systems in its new North Brunswick, NJ facility, and two additional systems in its Geneva discovery and production center. The deal makes Zymark the sole provider of automation technology for GeneProt in the US and Europe.

 

Zymark will also get a nonexclusive license and right of first negotiation to GeneProt research discoveries in order to develop new consumable application kits. That use must not infringe upon GeneProt's own commercialization efforts or those of its partners in pharmaceuticals and diagnostics.

 

Zymark, based in Hopkinton, Mass., is also making an equity investment in GeneProt. Financial details of the deal were not disclosed.

 

The two companies said they also will jointly develop automation instruments: Zymark's proteomics system will be used to automate in-gel protein digestion, liquid handling steps, and protein and peptide-sample preparation for mass-spec analysis.

 

In December, GeneProt said that it was buying about $20 million worth of Micromass Q-Tof mass spec machines and services from Waters for its New Jersey facility.

 

That 100,000-square-foot center, projected to employ about 150 people, is now under construction. GeneProt expects it to open for business in the second quarter of 2002.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.